Monograph Capital
Transatlantic life sciences venture firm that finds and funds innovative science, aiming to translate promising research into life-changing treatments.
San Francisco, United States · 12+ investments · 10 portfolio companies
- Headquarters
- San Francisco, United States
- Founded
- 2021
- Website
- monograph.bio
- AUM
- $154.0M
- Portfolio Companies
- 10
- Total Investments
- 12
- Last Investment
- Jan 2026
- Geographic Focus
- United States, United Kingdom
Investment Thesis
Monograph Capital is a Venture Capital firm based in San Francisco, United States. It has made 12 investments, including Sudo Biosciences, Maxion Therapeutics and Autobahn Therapeutics. Focus areas include Life Sciences and Biotech.
Portfolio10
Co-investors24
Sign up to view co-investors
24 co-investors across 33 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×21 · Corporate VC ×2 · Sovereign Wealth Fund ×1 · 34 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/monograph-capital"><img src="https://indexed.vc/api/badge/investor/monograph-capital" alt="Monograph Capital on Indexed.vc" width="260" height="76" /></a>